Sanofi-aventis: Multaq Approved in the European Union for Patients With Atrial Fibrillation

November 30, 2009 --Sanofi-aventis announced today that the European Commission has granted marketing authorization for Multaq(R) (dronedarone - 400mg Tablets) in all 27 European member states.

The details can be read here.